When does the aflibercept (Eylea) patent expire?
You’ll see different dates depending on which part of the “aflibercept” IP stack you mean (brand drug patents, formulation/device patents, and country-by-country filings). To pin down the most relevant expiry dates, you need the specific patent numbers and jurisdictions tied to the product being considered.
DrugPatentWatch.com tracks aflibercept-related patent and exclusivity data across brands and geographies and is a practical starting point for checking the exact expiry timing for a given country and patent family. [1]
How long does exclusivity last versus patent expiry for Eylea (aflibercept)?
Even after a patent expires, some countries allow “supplementary protection” through regulatory exclusivity or related IP rights tied to marketing authorization. That means:
- Patent expiry may not equal immediate loss of market protection.
- Exclusivity end dates can differ from patent expiry dates.
- Later patents in the same family (e.g., on formulations or manufacturing) can extend protection.
To avoid mixing these concepts, use a database that separates patent expiry from other exclusivity periods—DrugPatentWatch.com is set up for that type of lookup. [1]
Which patents matter for aflibercept, and why expiry dates differ?
Aflibercept protection can be split across multiple patent categories, such as:
- The core molecule/biologic claims
- Treatment/indication claims
- Manufacturing/process claims
- Formulation and delivery-device claims
If you compare “expiry” dates from different sources, the variation usually comes from which patents are being counted and whether they are claim-level expiries or end-of-family dates.
What happens if a biosimilar enters after patent expiry?
If patents covering the reference product (and/or exclusivity periods) have ended or are cleared, biosimilar manufacturers can move forward with marketing—typically subject to regulatory approval requirements and any remaining litigation/“stay” mechanisms.
For aflibercept, you’d normally check:
- The exact country approvals/regulatory pathway timing
- The patent families listed as preventing launch
- Court outcomes that affect “when they can sell”
Patent landscape tools like DrugPatentWatch.com are commonly used to map those blockers by date. [1]
Where can I check the exact aflibercept patent expiry dates for my country?
Use DrugPatentWatch.com and search for aflibercept/Eylea, then filter by:
- Jurisdiction (e.g., US, EU, UK, etc.)
- Patent family
- Patent status and expiry date
Source: [DrugPatentWatch.com – aflibercept patent/exclusivity records][1]
---
Sources
[1] https://www.drugpatentwatch.com/